Anti-cancer medicine shortages in an oncology tertiary hospital of Pakistan: A five-year retrospective study [0.03%]
巴基斯坦肿瘤三级医院的抗癌药物短缺：一项五年的回顾性研究
Sundus Shukar,Caijun Yang,Shahbaz Ahmad Khan et al.
Sundus Shukar et al.
Objective: Anti-cancer medicine shortages are advancing challenges for patients and hospitals. This study aims to evaluate anti-cancer and supportive medicine shortages in a tertiary hospital in Pakistan and propose solut...
Anaphylaxis caused by pegylated recombinant human granulocyte colony-stimulating factor [0.03%]
聚乙二醇化重组人粒细胞集落刺激因子导致的过敏性休克
Chen Chen,Jian Qi,Juandong Wang
Chen Chen
Introduction: Pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF), is commonly used to prevent and/or treat neutropenia caused by tumor chemotherapy and radiotherapy with reduced clearance, inc...
Adverse drug reactions associated with doxorubicin and epirubicin: A descriptive analysis from VigiBase [0.03%]
基于VigiBase数据库的多柔比星和表阿霉素药品不良反应的描述性分析研究
Deborah A Matesun,Kofi Boamah Mensah,Peter Yamoah et al.
Deborah A Matesun et al.
Background: Cancer is one of the leading causes of death globally. Owing to high toxicity, patients using chemotherapy drugs have a higher risk for developing adverse drug reactions (ADRs). Pharmacovigilance studies are e...
A case of castration-resistant metastatic prostate cancer who continued treatment with enzalutamide after epileptic seizure [0.03%]
恩扎卢胺治疗的去势抵抗性转移前列腺癌癫痫发作后的病例报告
Ozden Demir,Guzin Demirag
Ozden Demir
Introduction: Enzalutamide is an androgen receptor inhibitor and is used in metastatic castration-resistant prostate cancer. Seizure is a rare side effect of enzalutamide. In this case, the patient had an epileptic seizur...
Bosutinib-induced massive pleural effusion: Cross-intolerance with all tyrosine kinase inhibitors [0.03%]
博苏替尼所致大量胸腔积液1例：与所有酪氨酸激酶抑制剂交叉不耐受
Nevin Alayvaz Aslan,Hande Oğul Hıncal,Özde Elver et al.
Nevin Alayvaz Aslan et al.
Background: The discovery of tyrosine kinase inhibitors provided a breakthrough in the treatment of chronic myeloid leukemia. Nowadays, the management of tyrosine kinase inhibitor-related side effects is one of the import...
Dimitrios Alexandris,Nektarios Alevizopoulos,Kostas Palamaris et al.
Dimitrios Alexandris et al.
Introduction: Anti-EGFR targeted anti-cancer treatment is associated with various skin adverse events. Cetuximab is often associated with acneiform papules and skin disorders. Hypertrichosis cited in face pinnae and eyela...
Review of novel and supplemental approvals of the targeted cancer drugs by the Food and Drug Administration in 2021 [0.03%]
美国食品药品监督管理局2021年批准的靶向抗癌新药和补充适应症药物盘点
Esin Aysel Kandemir
Esin Aysel Kandemir
Objective: This review aims to present the most recent results from clinical trials of targeted cancer drugs that led to the Food and Drug Administration approval in 2021 and reflect the changing treatment landscape of so...
Safety and tolerability of lenalidomide maintenance dosing in patients with multiple myeloma post-autologous stem cell transplant [0.03%]
来那度胺维持治疗多发性骨髓瘤自体造血干细胞移植后患者的疗效和耐受性分析
Abigail Shockley,James A Davis,Kelly J Gaffney et al.
Abigail Shockley et al.
Background: For transplant-eligible newly diagnosed multiple myeloma patients, autologous hematopoietic stem cell transplant followed by maintenance lenalidomide is a standard of care practice. Maintenance lenalidomide do...
Development and reliability testing of a cervical cancer patients knowledge and practice of self-care management of treatment-related adverse events questionnaire [0.03%]
宫颈癌患者治疗相关不良事件自我管理的知识和行为量表的编制及信效度检测
Aliyu Samaila,Abdulmuminu Isah,Aminu A Biambo et al.
Aliyu Samaila et al.
Introduction: Cervical cancer (CC) treatment-related adverse events (AEs) were found to be among the major reasons for treatments delays and medication non-adherence. Knowledge and practice of self-care management of thes...